Cargando…

Potential Risks Associated with the Proposed Widespread Use of Tamiflu

BACKGROUND: The threat of pandemic influenza has focused attention and resources on virus surveillance, prevention, and containment. The World Health Organization has strongly recommended the use of the antiviral drug Tamiflu both to treat and prevent pandemic influenza infection. A major concern fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Singer, Andrew C., Nunn, Miles A., Gould, Ernest A., Johnson, Andrew C.
Formato: Texto
Lenguaje:English
Publicado: National Institute of Environmental Health Sciences 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1797841/
https://www.ncbi.nlm.nih.gov/pubmed/17366827
http://dx.doi.org/10.1289/ehp.9574
_version_ 1782132324757929984
author Singer, Andrew C.
Nunn, Miles A.
Gould, Ernest A.
Johnson, Andrew C.
author_facet Singer, Andrew C.
Nunn, Miles A.
Gould, Ernest A.
Johnson, Andrew C.
author_sort Singer, Andrew C.
collection PubMed
description BACKGROUND: The threat of pandemic influenza has focused attention and resources on virus surveillance, prevention, and containment. The World Health Organization has strongly recommended the use of the antiviral drug Tamiflu both to treat and prevent pandemic influenza infection. A major concern for the long-term efficacy of this strategy is to limit the development of Tamiflu-resistant influenza strains. However, in the event of a pandemic, hundreds of millions of courses of Tamiflu, stockpiled globally, will be rapidly deployed. Given its apparent resistance to biodegradation and hydrophilicity, oseltamivir carboxylate (OC), the active antiviral and metabolite of Tamiflu, is predicted to enter receiving riverwater from sewage treatment works in its active form. OBJECTIVE: Our objective in this study was to determine the likely concentrations of OC released into U.S. and U.K. river catchments using hydrologic modeling and current assumptions about the course and management of an influenza pandemic. DISCUSSION: We predict that high concentrations of OC (micrograms per liter) capable of inhibiting influenza virus replication would be sustained for periods of several weeks, presenting an increased risk for the generation of antiviral resistance and genetic exchange between influenza viruses in wildfowl. Owing to the apparent recalcitrance of OC in sewage treatment works, widespread use of Tamiflu during an influenza pandemic also poses a potentially significant, uncharacterized, ecotoxicologic risk in each affected nation’s waterways. CONCLUSION: To gauge the hazard presented by Tamiflu use during a pandemic, we recommend a) direct measurement of Tamiflu persistence, biodegradation, and transformation in the environment; b) further modeling of likely drug concentrations in the catchments of countries where humans and waterfowl come into frequent close contact, and where significant Tamiflu deployment is envisaged; and c) further characterization of the risks of generating Tamiflu-resistant viruses in OC-exposed wildfowl.
format Text
id pubmed-1797841
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher National Institute of Environmental Health Sciences
record_format MEDLINE/PubMed
spelling pubmed-17978412007-03-21 Potential Risks Associated with the Proposed Widespread Use of Tamiflu Singer, Andrew C. Nunn, Miles A. Gould, Ernest A. Johnson, Andrew C. Environ Health Perspect Research BACKGROUND: The threat of pandemic influenza has focused attention and resources on virus surveillance, prevention, and containment. The World Health Organization has strongly recommended the use of the antiviral drug Tamiflu both to treat and prevent pandemic influenza infection. A major concern for the long-term efficacy of this strategy is to limit the development of Tamiflu-resistant influenza strains. However, in the event of a pandemic, hundreds of millions of courses of Tamiflu, stockpiled globally, will be rapidly deployed. Given its apparent resistance to biodegradation and hydrophilicity, oseltamivir carboxylate (OC), the active antiviral and metabolite of Tamiflu, is predicted to enter receiving riverwater from sewage treatment works in its active form. OBJECTIVE: Our objective in this study was to determine the likely concentrations of OC released into U.S. and U.K. river catchments using hydrologic modeling and current assumptions about the course and management of an influenza pandemic. DISCUSSION: We predict that high concentrations of OC (micrograms per liter) capable of inhibiting influenza virus replication would be sustained for periods of several weeks, presenting an increased risk for the generation of antiviral resistance and genetic exchange between influenza viruses in wildfowl. Owing to the apparent recalcitrance of OC in sewage treatment works, widespread use of Tamiflu during an influenza pandemic also poses a potentially significant, uncharacterized, ecotoxicologic risk in each affected nation’s waterways. CONCLUSION: To gauge the hazard presented by Tamiflu use during a pandemic, we recommend a) direct measurement of Tamiflu persistence, biodegradation, and transformation in the environment; b) further modeling of likely drug concentrations in the catchments of countries where humans and waterfowl come into frequent close contact, and where significant Tamiflu deployment is envisaged; and c) further characterization of the risks of generating Tamiflu-resistant viruses in OC-exposed wildfowl. National Institute of Environmental Health Sciences 2007-01 2006-10-11 /pmc/articles/PMC1797841/ /pubmed/17366827 http://dx.doi.org/10.1289/ehp.9574 Text en http://creativecommons.org/publicdomain/mark/1.0/ Publication of EHP lies in the public domain and is therefore without copyright. All text from EHP may be reprinted freely. Use of materials published in EHP should be acknowledged (for example, ?Reproduced with permission from Environmental Health Perspectives?); pertinent reference information should be provided for the article from which the material was reproduced. Articles from EHP, especially the News section, may contain photographs or illustrations copyrighted by other commercial organizations or individuals that may not be used without obtaining prior approval from the holder of the copyright.
spellingShingle Research
Singer, Andrew C.
Nunn, Miles A.
Gould, Ernest A.
Johnson, Andrew C.
Potential Risks Associated with the Proposed Widespread Use of Tamiflu
title Potential Risks Associated with the Proposed Widespread Use of Tamiflu
title_full Potential Risks Associated with the Proposed Widespread Use of Tamiflu
title_fullStr Potential Risks Associated with the Proposed Widespread Use of Tamiflu
title_full_unstemmed Potential Risks Associated with the Proposed Widespread Use of Tamiflu
title_short Potential Risks Associated with the Proposed Widespread Use of Tamiflu
title_sort potential risks associated with the proposed widespread use of tamiflu
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1797841/
https://www.ncbi.nlm.nih.gov/pubmed/17366827
http://dx.doi.org/10.1289/ehp.9574
work_keys_str_mv AT singerandrewc potentialrisksassociatedwiththeproposedwidespreaduseoftamiflu
AT nunnmilesa potentialrisksassociatedwiththeproposedwidespreaduseoftamiflu
AT gouldernesta potentialrisksassociatedwiththeproposedwidespreaduseoftamiflu
AT johnsonandrewc potentialrisksassociatedwiththeproposedwidespreaduseoftamiflu